Back to GetFilings.com



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 


 

FORM 10-Q

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended March 31, 2003

 

 

OR

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the transition period from          to          

 

Commission File Number: 0-30822

 


 

SYNAVANT Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

22-2940965

(State of Incorporation)

 

(I.R.S. Employer Identification No.)

 

 

 

3445 Peachtree Road NE, Suite 1400
Atlanta, GA

 

30326

(Address of principal executive offices)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code (404) 841-4000

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ý No o

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

Title of Class

 

Shares Outstanding
at April 30, 2003

Common Stock,
par value $.01 per share

 

15,242,578 Shares

 

 



 

SYNAVANT Inc.

FORM 10-Q

FOR THE QUARTER ENDED MARCH 31, 2003

 

INDEX

 

PART I.

FINANCIAL INFORMATION

 

 

ITEM 1.

FINANCIAL STATEMENTS

 

 

 

Condensed Consolidated Balance Sheets as of March 31, 2003 and December 31, 2002

 

 

 

Consolidated Statements of Operations for the Three Months Ended March 31, 2003 and 2002

 

 

 

Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2003 and 2002

 

 

 

Notes to Consolidated Financial Statements

 

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

 

PART II.

OTHER INFORMATION

 

 

ITEM 1.

LEGAL PROCEEDINGS

 

 

ITEM 2.

CHANGES IN SECURITIES AND USE OF PROCEEDS

 

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

 

ITEM 4.

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

 

ITEM 5.

OTHER INFORMATION

 

 

ITEM 6.

EXHIBITS AND REPORTS ON FORM 8-K

 

 

SIGNATURES

 

2



 

PART I. FINANCIAL INFORMATION

 

ITEM I. FINANCIAL STATEMENTS

 

SYNAVANT Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollar amounts in thousands, except per share data)

 

 

 

March 31,
2003

 

December 31,
2002

 

 

 

(Unaudited)

 

(Audited)

 

ASSETS:

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

Cash and cash equivalents

 

$

10,146

 

$

6,994

 

Restricted cash

 

1,364

 

 

Accounts receivable—net

 

29,941

 

36,469

 

Other receivables

 

1,171

 

334

 

Other current assets

 

6,483

 

5,504

 

TOTAL CURRENT ASSETS

 

49,105

 

49,301

 

 

 

 

 

 

 

Property, plant and equipment—net

 

12,176

 

12,829

 

Computer software—net

 

2,342

 

2,682

 

Goodwill—net

 

41,156

 

41,156

 

Other assets

 

2,388

 

2,769

 

 

 

 

 

 

 

TOTAL ASSETS

 

$

107,167

 

$

108,737

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY:

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

Accounts payable

 

$

12,139

 

$

9,193

 

Line of credit

 

4,500

 

 

Accrued restructuring

 

1,374

 

2,109

 

Accrued and other current liabilities

 

14,724

 

16,219

 

Accrued income taxes

 

1,961

 

2,074

 

Deferred revenues

 

9,784

 

8,180

 

TOTAL CURRENT LIABILITIES

 

44,482

 

37,775

 

 

 

 

 

 

 

Accrued liability due to former parent

 

9,000

 

9,000

 

Other liabilities

 

1,671

 

1,966

 

TOTAL LIABILITIES

 

$

55,153

 

$

48,741

 

 

 

 

 

 

 

Commitments and contingencies (see note 2)

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

Common stock, par value $.01, authorized 41,000,000 shares; 15,242,578 and 15,187,722 shares outstanding at March 31, 2003 and December 31, 2002, respectively

 

152

 

152

 

Other stockholders’ equity

 

51,862

 

59,844

 

TOTAL STOCKHOLDERS’ EQUITY

 

52,014

 

59,996

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

$

107,167

 

$

108,737

 

 

See accompanying Notes to the Consolidated Financial Statements (unaudited).

 

3



 

SYNAVANT Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Dollar amounts in thousands, except per share data)

 

 

 

Three Months Ended
March 31,

 

 

 

2003

 

2002

 

 

 

 

 

 

 

REVENUES:

 

 

 

 

 

Software fees

 

$

174

 

$

1,440

 

Software services

 

16,636

 

20,848

 

Interactive marketing

 

18,005

 

22,672

 

TOTAL REVENUES

 

34,815

 

44,960

 

 

 

 

 

 

 

OPERATING COSTS:

 

 

 

 

 

Software fees

 

62

 

726

 

Software services

 

13,155

 

15,106

 

Interactive marketing

 

15,598

 

19,259

 

TOTAL OPERATING COSTS

 

28,815

 

35,091

 

 

 

 

 

 

 

Research & development

 

1,308

 

1,939

 

Selling and administrative expenses

 

8,397

 

7,596

 

Restructuring costs

 

500

 

 

Depreciation and amortization

 

1,881

 

1,838

 

OPERATING LOSS

 

(6,086

)

(1,504

)

Other expense—net

 

(1,023

)

(100

)

LOSS BEFORE PROVISION FOR INCOME TAXES

 

(7,109

)

(1,604

)

Income tax provision

 

(349

)

(341

)

NET LOSS

 

$

(7,458

)

$

(1,945